Mural Oncology PLC
Clinical-stage biotech developing novel cytokine-based cancer immunotherapies.
MURA | BUD
Overview
Corporate Details
- ISIN(s):
- IE000LK2BOB4
- LEI:
- Country:
- Ireland
- Address:
- N/A
- Website:
- https://www.muraloncology.com/
Description
Mural Oncology PLC is a clinical-stage biotechnology company that discovers and develops immunotherapies for cancer treatment. The company leverages its proprietary protein engineering platform to create novel, cytokine-based therapies. Its primary focus is on developing first- and best-in-class drugs for difficult-to-treat tumor types where other immunotherapies, such as checkpoint inhibitors, have not been effective. The company's pipeline is led by nemvaleukin alfa, a novel, engineered IL-2 variant immunotherapy. This candidate is being evaluated in clinical trials for various advanced solid tumors, including platinum-resistant ovarian cancer and advanced melanoma, addressing areas of high unmet medical need.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-05 13:45 |
Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion …
|
English | HTML • 9.3 KB | ||
| 2025-12-03 22:30 |
Mural Oncology Announces Sanction of the Scheme by the High Court
|
English | HTML • 12.8 KB | ||
| 2025-11-26 15:00 |
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisi…
|
English | HTML • 10.1 KB | ||
| 2025-10-24 22:25 |
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisiti…
|
English | HTML • 31.3 KB | ||
| 2025-09-24 01:52 |
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement …
|
English | HTML • 18.3 KB | ||
| 2025-08-20 14:30 |
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a …
|
English | HTML • 180.7 KB | ||
| 2025-05-19 21:57 |
Mural Oncology Announces Number of Relevant Securities in Issue
|
English | HTML • 9.0 KB | ||
| 2025-04-30 21:07 |
FORM 8.1(a) & (b) - Mural Oncology plc
|
English | HTML • 34.2 KB |
Automate Your Workflow. Get a real-time feed of all Mural Oncology PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Mural Oncology PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Mural Oncology PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
